Back to Search
Start Over
The efficacy and safety of influenza vaccination in older people: An umbrella review of evidence from meta-analyses of both observational and randomized controlled studies.
- Source :
-
Ageing Research Reviews . Sep2020, Vol. 62, pN.PAG-N.PAG. 1p. - Publication Year :
- 2020
-
Abstract
- • Healthcare professionals are aware of importance of vaccinations in older people. • This is the first umbrella review on safety and efficacy of vaccines in older age. • Vaccines decrease hospitalization for heart disease and for flu/ pneumonia by 27 %. • Influenza vaccines in the elderly should be administered on the large scale. Vaccination is the main public health intervention to prevent influenza. We aimed to evaluate the efficacy and safety of influenza vaccination including systematic reviews and meta-analyses of observational studies and randomized controlled trials (RCTs). Peer-reviewed systematic reviews with meta-analyses of prospective studies that investigated the association of influenza vaccination with any health-related outcome, as well as RCTs that investigated the efficacy and safety of influenza vaccination, were included. Among 1240 references, 6 meta-analyses were included. In cohort studies of community-dwelling older people influenza vaccination was associated with a lower risk of hospitalization for heart disease and for influenza/pneumonia (strength of evidence: convincing). Evidence in lowering the risk of mortality in community-dwelling older people, of all deaths/severe respiratory diseases in high risk community-dwelling older people and of hospitalization for influenza/pneumonia in case-control studies, was highly suggestive. In RCTs, influenza vaccination, compared to placebo/no intervention, was associated to higher risk of local tenderness/sore arm and to a reduced risk of influenza like-illness. Both these associations showed moderate evidence using the GRADE (Grading of Recommendations Assessment, Development and Evaluation). In conclusion, influenza vaccination in older people seems safe and effective. Further, the evidence on safety and efficacy of vaccines in this population might benefit by an extension of the follow-up period both in RCTs and in longitudinal studies, beyond the usual 6-month period, in order to be able to evaluate the impact of vaccination on long term outcomes. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15681637
- Volume :
- 62
- Database :
- Academic Search Index
- Journal :
- Ageing Research Reviews
- Publication Type :
- Academic Journal
- Accession number :
- 145498537
- Full Text :
- https://doi.org/10.1016/j.arr.2020.101118